Iron Deficiency & Folic acid Deficiency anemia. Iron deficiency anaemia, unspecified & Folate deficiency anaemia, unspecified
Conditions
Interventions
Each patient received irpo-FA (combination tablet of Iron Polymaltose (100mg elemental iron) & 0.35 mg folic acid oral tablets O. D, following the instructions as chew the tablets on empty stomach, 1
Treatment - Drugs
Sponsors
Nabiqasim Industries (Pvt) Ltd.
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Pregnant Women in second or third trimester or after 12 weeks of pregnancy, Hb: = 10. 5g/dl after first trimester and serum ferritin levels are below than normal (less than 35 µg/l) Exclusion Criteria: Patient with a history of non-compliance with iron therapy or allergic to iron preparation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increase of 1g/dl Hb with 100-200mg/day elemental iron. Timepoint: 2 weeks, 1 month, 2 months and three months after initiation of oral iron therapy. Method of measurement: C. B. C, Ferritin, iron profile tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal adverse events. Timepoint: At every visit and Follow up checkups. Method of measurement: Patient monitoring & Follow up calls to patients. | — |
Countries
Pakistan
Contacts
Public ContactSalman Rahim
Nabiqasim Industries (Pvt) Ltd.
Outcome results
None listed